Log in

Relevant bibliographies by topics / Interruption of drug delivery / Journal articles

To see the other types of publications on this topic, follow the link: Interruption of drug delivery.

Journal articles on the topic 'Interruption of drug delivery'

Author: Grafiati

Published: 4 June 2021

Last updated: 3 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Interruption of drug delivery.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Zahid, Aisha, Andrew Wignell, Dusan Raffaj, and Patrick Davies. "P57 Continuous drug delivery is significantly affected by relative height changes between patient and syringe driver." Archives of Disease in Childhood 105, no. 9 (2020): e36.1-e36. http://dx.doi.org/10.1136/archdischild-2020-nppg.65.

Full text

Abstract:

AimsSyringe drivers are the principle method of giving continuous infusions of important drugs to patients. Many of these drugs are critical for the maintenance of normal physiology. Anecdotal evidence abounds of severe patient instability on movement of syringe drivers during infusion. Our objective was to define the variation in drug delivery seen in three different syringe drivers, with changes in relative height between the syringe driver and the end of the giving set.MethodsThree syringe drivers (Alaris CC (Becton Dickinson), Perfusor Space (B Braun), and Synamed μSP6000 (Arcomed)) were a

APA, Harvard, Vancouver, ISO, and other styles

2

Huang, Dongdong, Ke Wu, Ying Zhang, et al. "Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke." REVIEWS ON ADVANCED MATERIALS SCIENCE 58, no. 1 (2019): 159–70. http://dx.doi.org/10.1515/rams-2019-0024.

Full text

Abstract:

Abstract Stroke is an acute cerebrovascular disorder caused by sudden decrease or interruption of blood flow in brain arteries. Deficiency of timely and effective reperfusion of ischemic brain tissue can lead to irreversible brain injury and neurological dysfunction. Currently, recombinant tissue plasminogen activator (rt-PA) is the only appropriate thrombolytic agent which is approved by FDA for patients with acute ischemic stoke. However, due to the limitation of very narrow therapeutic time window and severe intracranial hemorrhagic complication, the outcome of stroke treatment mediated by

APA, Harvard, Vancouver, ISO, and other styles

3

Crist, MacKenzie, Ashkan Emadi, and Alison Duffy. "Real-world experience managing blinatumomab toxicities in adults with relapsed/refractory acute lymphoblastic leukemia." Journal of Oncology Pharmacy Practice 26, no. 5 (2019): 1080–85. http://dx.doi.org/10.1177/1078155219881680.

Full text

Abstract:

Purpose The purpose of this study was to determine the effect of blinatumomab toxicities on drug therapy modifications in an intended 28-day course of blinatumomab therapy. Methods Patients with acute lymphoblastic leukemia who received blinatumomab at the University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center from March 1, 2015 to April 30, 2018 were included. The primary objective of this study was to identify the frequency and severity of blinatumomab toxicities that led to drug therapy modifications; secondary objectives were to identify the frequency and durat

APA, Harvard, Vancouver, ISO, and other styles

4

Бойко, А. В., Н. Д. Олтаржевская, В. И. Швец, et al. "New opportunities of drug delivery in oncology." ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia», no. 3() (September 14, 2018): 120–27. http://dx.doi.org/10.25557/0031-2991.2018.03.120-127.

Full text

Abstract:

Цель исследования. Разработка методов сопроводительной терапии для защиты нормальных органов и тканей, входящих в зону облучения. Методы. В исследование включено 112 больных раком шейки и тела матки после комбинированного или самостоятельного лучевого лечения с 2012 по 2016 гг. У 71 пациентки основной группы в качестве терапии сопровождения применяли гидрогель с деринатом и у 41 больной группы контроля - традиционные методы профилактики (масло оливковое, подсолнечное, метилурациловая мазь). Для профилактики эпителиита слизистой влагалища и шейки матки в основной группе использовали гидрогель в

APA, Harvard, Vancouver, ISO, and other styles

5

Gupta, Tejpal, Rahul Krishnatry, Ankita A. Nachankar, and Jai Prakash Agarwal. "Oral Radiation Mucositis: A Short Review." International Journal of Head and Neck Surgery 2, no. 1 (2011): 37–43. http://dx.doi.org/10.5005/jp-journals-10001-1045.

Full text

Abstract:

ABSTRACT Oral radiation mucositis is one of the debilitating and dose-limiting acute toxicity during (chemo) radiation or for HNC having a major impact on the patient daily functioning, well-being and quality of life. The unplanned interruption of treatment secondary to mucositis may compromise the treatment and the outcomes if not adequately addressed. Recently, the integrated pathophysiological mechanism of radiation injury has been proposed, aiding development of certain targeted therapies for the prevention and treatment of oral mucositis. Although there are currently no approved agents or

APA, Harvard, Vancouver, ISO, and other styles

6

Barr, Thomas R., Elaine L. Towle, Thomas R. Barr, and Elaine L. Towle. "ReCAP: The ASCO Oncology Composite Provider Utilization File: New Data, New Insights." Journal of Oncology Practice 12, no. 1 (2016): 69–70. http://dx.doi.org/10.1200/jop.2015.008516.

Full text

Abstract:

QUESTION ASKED: What can we learn regarding oncology practice economics from the Centers for Medicare & Medicaid Services public use files and other publicly available datasets? SUMMARY ANSWER: By combining and analyzing publicly available datasets, we are able to provide information on the distribution of supply of and demand for oncology services as well as present a clear picture of the financial risks associated with the provision of drug therapies to patients with cancer. METHODS: We combined publicly available datasets into what we call the ASCO Provider Utilization File and used it

APA, Harvard, Vancouver, ISO, and other styles

7

Penn, Richard D. "Intrathecal baclofen for spasticity of spinal origin: seven years of experience." Journal of Neurosurgery 77, no. 2 (1992): 236–40. http://dx.doi.org/10.3171/jns.1992.77.2.0236.

Full text

Abstract:

✓ A total of 66 consecutive patients with severe spasticity of spinal cord origin were screened with intrathecal baclofen, and all but two responded with a two-point decrease in their Ashworth spasticity scale and/or spasm scale score. Of these, 62 elected to receive chronic intrathecal baclofen administration by means of an implanted delivery system. These patients have been followed for an average of 30 months (the first three for 81 months). Intrathecal baclofen has been well tolerated and all serious side effects were transient and have been managed by dose adjustments. The pump presently

APA, Harvard, Vancouver, ISO, and other styles

8

Lesnic, Evelina, Aurelia Ustian, and Carmen Monica Pop. "The role of exogenous risk factors of antituberculosis treatment failure." Medicine and Pharmacy Reports 89, no. 3 (2016): 396–401. http://dx.doi.org/10.15386/cjmed-608.

Full text

Abstract:

Background and aim. The Republic of Moldova reports the highest incidence of tuberculosis and the lowest treatment success rate among European region countries. In most of the patients the antituberculosis treatment failure is correlated with social risk factors (low socio-economical state, epidemiological danger characteristics) and biological factors (young age, male sex, physiological conditions, associated diseases). Clinical factors (advanced forms of tuberculosis, chronic evolution, immune disturbances), therapeutic factors (treatment errors and interruptions, individualized regimens) an

APA, Harvard, Vancouver, ISO, and other styles

9

Santos, Daniela Braz dos, José Teófilo Moreira-Filho, Amanda de Oliveira Melo, et al. "In silico-driven identification of novel molluscicides effective against Biomphalaria glabrata (Say, 1818)." New Journal of Chemistry 44, no. 39 (2020): 16948–58. http://dx.doi.org/10.1039/d0nj03314f.

Full text

Abstract:

Schistosomiasis control in endemic areas depends on several factors, including mass drug delivery programs and interrupting the transmission of disease by controlling the intermediate host snails in the freshwater ecosystem using molluscicides.

APA, Harvard, Vancouver, ISO, and other styles

10

McNeil, Ryan, and Manal Guirguis-Younger. "Illicit drug use as a challenge to the delivery of end-of-life care services to homeless persons: Perceptions of health and social services professionals." Palliative Medicine 26, no. 4 (2011): 350–59. http://dx.doi.org/10.1177/0269216311402713.

Full text

Abstract:

Homeless persons tend to die younger than the housed population and have complex, often unmet, end-of-life care needs. High levels of illicit drug use among this population are a particular challenge for health and social services professionals involved in end-of-life care services delivery. This article explores the challenges of end-of-life care services to homeless illicit drug users based on data collected during a national study on end-of-life care services delivery to homeless persons in Canada. The authors conducted qualitative interviews with 50 health and social services professionals

APA, Harvard, Vancouver, ISO, and other styles

11

Nakajima, Y., and S. R. Pfeffer. "Phosphatidylinositol 3-kinase is not required for recycling of mannose 6-phosphate receptors from late endosomes to the trans-Golgi network." Molecular Biology of the Cell 8, no. 4 (1997): 577–82. http://dx.doi.org/10.1091/mbc.8.4.577.

Full text

Abstract:

Mannose 6-phosphate receptors carry newly synthesized lysosomal hydrolases from the trans-Golgi network to endosomes, then return to the trans-Golgi network for another round of enzyme delivery. Wortmannin, an inhibitor of phosphatidylinositol 3-kinase, interferes with the delivery of newly synthesized lysosomal enzymes to lysosomes. We used two independent assays of mannose 6-phosphate receptor trafficking to determine the precise step that is blocked by wortmannin. Using an assay that monitors resialylation of desialylated cell surface 300-kDa mannose 6-phosphate receptors, we found that rec

APA, Harvard, Vancouver, ISO, and other styles

12

Horowitz, Marc E., Larry E. Kun, Raymond K. Mulhern, et al. "Feasibility and Efficacy of Preirradiation Chemotherapy for Pediatric Brain Tumors." Neurosurgery 22, no. 4 (1988): 687–90. http://dx.doi.org/10.1227/00006123-198804000-00011.

Full text

Abstract:

Abstract Preirradiation chemotherapy is a potentially important component of combined treatment for brain tumors; however, concerns over its side effects and antitumor activity have impeded its evaluation in clinical trials. To determine the feasibility of administering such therapy to children, we assessed the responses of 38 brain tumor patients (median age, 2 years) to 12 weeks of combination chemotherapy given after surgical resection but before irradiation. Transient myelosuppression was noted in all patients, but was not associated with infections or complications of surgical wounds. The

APA, Harvard, Vancouver, ISO, and other styles

13

Alam, Farrukh, and Peter Barker. "Interruption of medication-assisted treatment for opioid dependence: insights from the UK." Drugs and Alcohol Today 14, no. 3 (2014): 114–25. http://dx.doi.org/10.1108/dat-01-2014-0002.

Full text

Abstract:

Purpose – The purpose of this paper is to identify risk factors for interruptions in opioid dependence treatment and barriers to (re) entering effective treatment through real-world insight on current opioid dependence treatment in the UK. Design/methodology/approach – Project Access UK, a national survey deployed across multiple regions in England, Wales and Scotland, collected data on the perspectives of patients receiving medication-assisted treatment (MAT) for opioid dependence (n=248), out-of-treatment opioid users (n=196), and physicians (n=100). Findings – Both patients and users report

APA, Harvard, Vancouver, ISO, and other styles

14

Rosti, Gianantonio, Fausto Castagnetti, Francesca Palandri, et al. "Nilotinib 800 Mg Daily as Frontline Therapy of Ph + Chronic Myeloid Leukemia: Dose Delivered and Safety Profile for the GIMEMA CML Working Party." Blood 114, no. 22 (2009): 2205. http://dx.doi.org/10.1182/blood.v114.22.2205.2205.

Full text

Abstract:

Abstract Abstract 2205 Poster Board II-182 Nilotinib is an effective and registered treatment of chronic myeloid leukemia (CML) after imatinib failure. Its efficacy as frontline treatment has been explored in phase 2 trials from MDACC and Italian GIMEMA , whose results have been presented recently (Cortes ASH Rosti, EHA). Here we present a detailed analysis of the safety profile of nilotinib 800 mg daily in the CML early chronic phase (ECP) setting. Briefly, 73 ECP patients (median age 51 yrs, range 18-83 yrs, 21/73 – 29% - ≥ 65 yrs at enrolment) received nilotinib at a dose of 400 mg BID. Wit

APA, Harvard, Vancouver, ISO, and other styles

15

Chaturvedi, Priyanka, Anurag Singh, Payal Agrawal, and Surendra Jain. "USING THE BOX–BEHNKEN EXPERIMENTAL DESIGN DEVELOPMENT OF GASTRORETENTIVE MUCOADHESIVE MICROSPHERES OF SIMVASTATIN BY SPRAY DRYING METHOD." INDIAN DRUGS 57, no. 10 (2021): 65–70. http://dx.doi.org/10.53879/id.57.10.12475.

Full text

Abstract:

Simvastatin is an antihyper-lipidemic drug which inhibits HMG-CoA reductase, interrupting cholesterol synthesis. It is poorly water soluble drug having very low bioavailability (5%). It is having better absorption in upper gastro intestinal tract. Due to lower bioavailability and short biological half-life simvastatin is prescribed 2-3 times a day which leads to lower patient compliance. The aim of the present work was to prepare controlled release microspheres which and retained in the gastric area by adhering to the mucosal membrane for longer period of time. It was a also proposed to design

APA, Harvard, Vancouver, ISO, and other styles

16

Fu, Yige, Drishti Rathod, Ehab Abo-Ali, Vikas Dukhande, and Ketan Patel. "EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma." Pharmaceutics 11, no. 10 (2019): 504. http://dx.doi.org/10.3390/pharmaceutics11100504.

Full text

Abstract:

The clinical outcomes of malignant melanoma have improved with the introduction of mitogen-activated protein kinase kinase (MEK) inhibitors. However, off-target toxicities of the MEK inhibitor trametinib (TMB) often result in dose interruption and discontinuation of therapy. The purpose of this study was to anchor a physically stable EphrinA1-mimicking peptide known as YSA (YSAYPDSVPMMS) on TMB-loaded PEGylated nanoliposomes (YTPLs), and evaluate them in BRAFV600E-mutated parent cells (lines A375 and SK-MEL-28) and vemurafenib-resistant cells lines (A375R and SK-MEL-28R) in melanoma. TMB-loade

APA, Harvard, Vancouver, ISO, and other styles

17

Pilotto, Jose Henrique, Beatriz Grinsztejn, Valdilea Veloso, et al. "High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil." Retrovirology 6, Suppl 1 (2009): O14. http://dx.doi.org/10.1186/1742-4690-6-s1-o14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Siregar, Deborah, Erivita Sakti, and Alfrida Siringoringo. "The Risk Factors Of Nurses' Non-Compliance To The Principles Of Five Rights in Drug Administration in Patient Wards in One Of The Private Hospitals in West Indonesia." Nursing Current Jurnal Keperawatan 6, no. 1 (2018): 34. http://dx.doi.org/10.19166/nc.v6i1.1284.

Full text

Abstract:

<p>Medication administration errors (MAEs) are one of the risks in nursing practice and occur because the drugs received by patients with prescription drugs are not appropriate. Nurses play an important role in patient safety, especially in drug delivery. The principle of five correct is needed to prevent the incidence of MAE. The causes of MAE are interruptions, workload, knowledge, and communication. The purpose of this study was to analyze the most influential factors on the incidence of MAE in a hospital West Indonesia. The research design used cross sectional. The sampling technique

APA, Harvard, Vancouver, ISO, and other styles

19

Fleming, Taylor, Alexandra B. Collins, Geoff Bardwell, et al. "A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs." PLOS ONE 16, no. 2 (2021): e0246999. http://dx.doi.org/10.1371/journal.pone.0246999.

Full text

Abstract:

Antiretroviral therapy (ART) dispensing is strongly associated with treatment adherence. Among illicit drug-using populations, whom experience greater structural barriers to adherence, directly administered antiretroviral therapy (DAAT) is often regarded as a stronger predictor of optimal adherence over self-administered medications. In Vancouver, Canada, people living with HIV (PLHIV) who use drugs and live in low-income housing are a critical population for treatment support. This group is typically able to access two key DAAT models, daily delivery and daily pickup, in addition to ART self-

APA, Harvard, Vancouver, ISO, and other styles

20

Pilon, Dominic, Ajay S. Behl, Bruno Emond, Yongling Xiao, Patrick Lefebvre, and Christopher J. Kane. "Refill gaps and dose reductions in patients treated with abiraterone acetate plus prednisone (AA+P) or enzalutamide (ENZ)." Journal of Clinical Oncology 35, no. 6_suppl (2017): e572-e572. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.e572.

Full text

Abstract:

e572 Background: Recently available treatmentssuch as AA+P or ENZ have improved survival and quality of life for patients with metastatic castrate resistant prostate cancer (mCRPC). However, drug-drug interactions, intolerance or toxicities can potentially lead to dose reductions or treatment interruption. This study assessed refill gaps and dose reduction events in patients treated with AA+P or ENZ. Methods: The MarketScan databases (03/2012-10/2015) were used to conduct a retrospective analysis. Patients initiated on AA+P or ENZ (index date) after 09/2012 with ≥ 6 months of continuous eligib

APA, Harvard, Vancouver, ISO, and other styles

21

Weiss, Brian D., Melissa Scott, Kathleen Demmel, Uma R. Kotagal, John P. Perentesis, and Kathleen E. Walsh. "Significant and Sustained Reduction in Chemotherapy Errors Through Improvement Science." Journal of Oncology Practice 13, no. 4 (2017): e329-e336. http://dx.doi.org/10.1200/jop.2017.020842.

Full text

Abstract:

Purpose: A majority of children with cancer are now cured with highly complex chemotherapy regimens incorporating multiple drugs and demanding monitoring schedules. The risk for error is high, and errors can occur at any stage in the process, from order generation to pharmacy formulation to bedside drug administration. Our objective was to describe a program to eliminate errors in chemotherapy use among children. Methods: To increase reporting of chemotherapy errors, we supplemented the hospital reporting system with a new chemotherapy near-miss reporting system. After the model for improvemen

APA, Harvard, Vancouver, ISO, and other styles

22

Weiss, Brian D., Melissa Scott, Kathleen Demmel, John Peter Perentesis, Uma R. Kotagal, and Kathleen Walsh. "Significant and sustained reduction in chemotherapy errors though improvement science." Journal of Clinical Oncology 35, no. 8_suppl (2017): 37. http://dx.doi.org/10.1200/jco.2017.35.8_suppl.37.

Full text

Abstract:

37 Background: The majority of children with cancer are now cured with highly complex chemotherapy regimens incorporating multiple drugs and demanding monitoring schedules. The risk for error is high and can occur at any stage in the process, from order generation through pharmacy formulation to bedside drug administration. Our objective is to describe a program to eliminate errors in chemotherapy use among children. Methods: To increase reporting of chemotherapy errors, we supplemented the hospital-reporting system with a new chemotherapy near-miss reporting system. Following the model for im

APA, Harvard, Vancouver, ISO, and other styles

23

Wen, Susanna, Michelle Richardson, Ryo Kita, Donna Stram, and Hiroomi Tada. "An Observational Study to Collect and Assess Tissue Samples from Subjects with One of Three Neoplastic Conditions (ANSWer)." Blood 136, Supplement 1 (2020): 44–45. http://dx.doi.org/10.1182/blood-2020-140185.

Full text

Abstract:

Background: Multiple studies have demonstrated that established human cancer cell lines are inadequate to model intra- and inter-patient tumor heterogeneity and resulting mechanisms of disease resistance and progression. Ex vivo drug sensitivity screening (DSS) on primary patient samples may provide a unique approach to overcome these limitations, unlocking insights into drug resistance and identify novel combination therapies that overcome resistance. Notable Labs has built an automated, flow-cytometry-based high-throughput DSS platform that enables testing hundreds of drugs and combinations

APA, Harvard, Vancouver, ISO, and other styles

24

Elarabi, Hesham, Abuelgasim Elrasheed, Ahmed Ali, et al. "Suboxone Treatment and Recovery Trial (STAR-T): Study Protocol for a Randomised Controlled Trial of Opioid Medication Assisted Treatment with Adjunctive Medication Management Using Therapeutic Drug Monitoring and Contingency Management." Journal of Addiction 2019 (March 5, 2019): 1–11. http://dx.doi.org/10.1155/2019/2491063.

Full text

Abstract:

Introduction. Opioid assisted treatment (OAT) with buprenorphine (BUP) is front-line medical maintenance intervention for illicit and prescription opioid use disorder (OUD). In many clinics, opioid medication is dispensed for several days for self-administration. This provides flexibility to the patient but may compromise the effectiveness of OAT because of nonadherence or medication diversion. OAT can be delivered as an entirely supervised intervention, but many patients discontinue treatment under this arrangement and dispensing costs may be prohibitive. An alternative is to enable patients

APA, Harvard, Vancouver, ISO, and other styles

25

Chiu, Tsu-Man, Ping-Chun Hsu, Mohd Yaqub Khan, et al. "A Perspective on Imiquimod Microneedles for Treating Warts." Pharmaceutics 13, no. 5 (2021): 607. http://dx.doi.org/10.3390/pharmaceutics13050607.

Full text

Abstract:

Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a synthetic compound that belongs to the imidazoquinolinone family. It has been successfully used as a topical drug to treat external anogenital warts. However, topical imiquimod cream for warts is restricted by low skin permeability, and several side effects such as itching, pain, and erosions occur

APA, Harvard, Vancouver, ISO, and other styles

26

Saso, Anja, Helen Skirrow, and Beate Kampmann. "Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint—The Immunising Pregnant Women and Infants Network." Vaccines 8, no. 3 (2020): 556. http://dx.doi.org/10.3390/vaccines8030556.

Full text

Abstract:

The COVID-19 pandemic response has caused disruption to healthcare services globally, including to routine immunizations. To understand immunization service interruptions specifically for maternal, neonatal and infant vaccines, we captured the local experiences of members of the Immunising Pregnant Women and Infants Network (IMPRINT) by conducting an online survey over 2-weeks in April 2020. IMPRINT is a global network of clinicians and scientists working in maternal and neonatal vaccinology. The survey included discrete questions to quantify the extent of disruption as well as free-text optio

APA, Harvard, Vancouver, ISO, and other styles

27

Garcia-Broncano, Pilar, Shivaali Maddali, Kevin B. Einkauf, et al. "Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile." Science Translational Medicine 11, no. 520 (2019): eaax7350. http://dx.doi.org/10.1126/scitranslmed.aax7350.

Full text

Abstract:

Neonatal HIV-1 infection is associated with rapidly progressive and frequently fatal immune deficiency if left untreated. Immediate institution of antiretroviral therapy (ART), ideally within hours after birth, may restrict irreversible damage to the developing neonatal immune system and possibly provide opportunities for facilitating drug-free viral control during subsequent treatment interruptions. However, the virological and immunological effects of ART initiation within hours after delivery have not been systematically investigated. We examined a unique cohort of neonates with HIV-1 infec

APA, Harvard, Vancouver, ISO, and other styles

28

Ranade, Vasant V. "Drug Delivery Systems. 6. Transdermal Drug Delivery." Journal of Clinical Pharmacology 31, no. 5 (1991): 401–18. http://dx.doi.org/10.1002/j.1552-4604.1991.tb01895.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Ranade, Vasant V. "Drug Delivery Systems 5A. Oral Drug Delivery." Journal of Clinical Pharmacology 31, no. 1 (1991): 2–16. http://dx.doi.org/10.1002/j.1552-4604.1991.tb01881.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Ranade, Vasant V. "Drug Delivery Systems 5B. Oral Drug Delivery." Journal of Clinical Pharmacology 31, no. 2 (1991): 98–115. http://dx.doi.org/10.1002/j.1552-4604.1991.tb03693.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Gadicherla, Suman, Lalitha Krishnappa, Bindu Madhuri, et al. "Envisioning a learning surveillance system for tuberculosis." PLOS ONE 15, no. 12 (2020): e0243610. http://dx.doi.org/10.1371/journal.pone.0243610.

Full text

Abstract:

Surveillance is critical for interrupting transmission of global epidemics. Research has highlighted gaps in the surveillance for tuberculosis that range from failure to collect real-time data to lack of standardization of data for informed decision-making at different levels of the health system. Our research aims to advance conceptual and methodological foundations for the development of a learning surveillance system for Tuberculosis, that involves systematic collection, analysis, interpretation, and feedback of outcome-specific data. It would concurrently involve the health care delivery s

APA, Harvard, Vancouver, ISO, and other styles

32

Campbell, Kimberly L., John R. Cohn, David L. Fischman, et al. "Management of Clopidogrel Hypersensitivity Without Drug Interruption." American Journal of Cardiology 107, no. 6 (2011): 812–16. http://dx.doi.org/10.1016/j.amjcard.2010.11.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

HENRY, CELIA M. "DRUG DELIVERY." Chemical & Engineering News 80, no. 34 (2002): 39–47. http://dx.doi.org/10.1021/cen-v080n034.p039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Weidner, John. "Drug Delivery." Drug Discovery Today 7, no. 24 (2002): 1230–31. http://dx.doi.org/10.1016/s1359-6446(02)02533-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Weidner, John. "Drug delivery." Drug Discovery Today 8, no. 19 (2003): 906–7. http://dx.doi.org/10.1016/s1359-6446(03)02830-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Siegel, Ronald A. "Drug Delivery." Journal of Controlled Release 93, no. 1 (2003): 86–88. http://dx.doi.org/10.1016/s0168-3659(03)00336-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Weidner, John. "Drug delivery." Drug Discovery Today 6, no. 4 (2001): 216–17. http://dx.doi.org/10.1016/s1359-6446(00)01645-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Weidner, John. "Drug delivery." Drug Discovery Today 6, no. 6 (2001): 327–28. http://dx.doi.org/10.1016/s1359-6446(01)01686-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Weidner, John. "Drug delivery." Drug Discovery Today 6, no. 9 (2001): 492–93. http://dx.doi.org/10.1016/s1359-6446(01)01754-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Weidner, John. "Drug delivery." Drug Discovery Today 6, no. 15 (2001): 809–10. http://dx.doi.org/10.1016/s1359-6446(01)01879-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Weidner, John. "Drug delivery." Drug Discovery Today 6, no. 21 (2001): 1129–30. http://dx.doi.org/10.1016/s1359-6446(01)01979-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Weidner, John. "Drug Delivery." Drug Discovery Today 7, no. 3 (2002): 207–8. http://dx.doi.org/10.1016/s1359-6446(01)02107-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Weidner, John. "Drug delivery." Drug Discovery Today 7, no. 7 (2002): 436–37. http://dx.doi.org/10.1016/s1359-6446(02)02205-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Weidner, John. "Drug delivery." Drug Discovery Today 7, no. 11 (2002): 632. http://dx.doi.org/10.1016/s1359-6446(02)02270-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Weidner, J. "Drug delivery." Drug Discovery Today 7, no. 15 (2002): 832–33. http://dx.doi.org/10.1016/s1359-6446(02)02326-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Pedersen, Søren. "Drug Delivery." American Journal of Respiratory and Critical Care Medicine 151, no. 2_pt_2 (1995): S27—S28. http://dx.doi.org/10.1164/ajrccm/151.2_pt_2.s27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Illum, Lisbeth, and Stanley S. Davis. "Drug delivery." Current Opinion in Biotechnology 2, no. 2 (1991): 254–59. http://dx.doi.org/10.1016/0958-1669(91)90018-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Baker, Dale. "Drug delivery." Annals of Biomedical Engineering 25, no. 1 (1997): S—3. http://dx.doi.org/10.1007/bf02647344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Kong, Lingzhong, Xiaohui Lei, Qian Yang, Hezhen zheng, and Hao Wang. "Automatic feedback control algorithm for canal for a quick upstream water supply interruption in the case of an emergency." MATEC Web of Conferences 246 (2018): 02026. http://dx.doi.org/10.1051/matecconf/201824602026.

Full text

Abstract:

For the sudden upstream water interruption in the canal of an emergency, the existing research method guiding gate control is mainly feed-forward compensation algorithm, under which algorithm the interruption of water diversions is the upstream first and then the downstream. In order to achieve a more flexible water demand for different water diversions purpose, this study used PI water level difference feedback control algorithm to control the gate under this condition. The research results showed that the PI water level difference feedback control algorithm can make the change trend of water

APA, Harvard, Vancouver, ISO, and other styles

50

Benson, Heather AE, and Richard J. Prankerd. "Optimisation of Drug Delivery: 4. Transdermal Drug Delivery." Australian Journal of Hospital Pharmacy 27, no. 6 (1997): 441–48. http://dx.doi.org/10.1002/jppr1997276441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!